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Editorial on the Research Topic
Leukocyte Trafficking in Homeostasis and Disease
Leukocytes move avidly through the body. While this is classically associated with immune
responses, leukocyte trafficking is just as prominent during steady-state conditions as they leave
the bone marrow (BM), home back to tissues for elimination, or traffic through secondary
lymphoid organs (1). However, immune cell trafficking becomes uncontrolled during inflammatory
pathologies (2, 3), and in the homing of hematologic tumor cells to BM and lymph nodes.
Diapedesis of immune cells and blood cancer cells across endothelium is facilitated by chemokines
and adhesion molecules, which act in concert in tightly regulated directional motility (1–6).
The Research Topic on “Leukocyte Trafficking in Homeostasis and Disease” covers several
reviews providing an up-to-date view of different molecular and cellular players that regulate key
trafficking processes during cell differentiation, immune responses and lymphocyte recirculation,
as well as in inflammatory pathologies and in hematological malignancies.
NEUTROPHIL TRAFFICKING
Integrins are key adhesion receptors controlling leukocyte trafficking. In their review, Fagerholm
et al. describe the critical roles of β2 integrins in leukocyte trafficking and other leukocyte functions
that are dependent on cell adhesion (7). The importance of β2 integrins for immune function
is shown by rare genetic disorders (Leukocyte adhesion deficiencies, or LAD) that affect their
expression (LAD-I) or function (LAD-III, caused by mutations in the integrin regulator, kindlin-
3) (8, 9). However, β2 integrins are also associated with many immune suppressive functions. For
example, they can inhibit tissue migration of dendritic cells, and also suppress cytokine responses
in myeloid cells (10–12). Because of these various roles in immunity, β2 integrin dysfunction can
contribute to the development of both immunodeficiency diseases and inflammatory diseases.
The classical leukocyte recruitment cascade consisting of leukocyte capture, rolling, arrest, firm
adhesion, crawling and finally, transmigration through the endothelium (2), is widely accepted as
the way leukocytes are recruited into tissues. Maas et al. describe the variations in the trafficking
rules that neutrophils use to enter different tissues, focusing on lung, liver, kidney and aorta. These
rules are distinct in different organs and tissues, and there appears to be significant redundancy
in the system (chemokines, etc.), which may explain why it is so difficult to target leukocyte
recruitment successfully in the clinic.
Focusing on themigratory dynamics of neutrophils, Morikis and Simon summarize an extensive
body of literature suggesting that biomechanical signals at the original site of interactions between
leukocytes and the activated endothelium critically regulate leukocyte adhesion and polarization.
The extensive, but poorly characterized interplay between multiple types of receptors (selectins,
glycoproteins, integrins, or calcium channels) in these regions is discussed to be critical at these
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early stages of the recruitment cascade. With the description of
how protein modules in integrins and cytoskeleton reorganize,
and the relevance of these events in controlling neutrophil
migration, Morikis and Simon provide an exciting review of the
intricate biomechanics of immunity.
Neutrophils must cross multiple barriers in the body to
reach the areas where they will perform their immune tasks
(13). An underappreciated aspect of this migration is how
the cell adapts to the constraints imposed by each barrier,
be it endothelial, matricial, or interstitial. Salvermoser et al.
discuss how neutrophils adapt to the varying environments,
and in particular focus on adaptations of nucleus, which is
the stiffest cellular organelle. As thoroughly reviewed by the
authors, nuclear architecture and deformability are key features
that allow the swift and efficientmigration of neutrophils through
multiple environments.
Leukocytes not only travel into peripheral tissues, but can
interestingly also regulate BM hematopoietic stem cells (HSC)
(14). The review by Lucas describes the HSC niche, its
components and its regulation by leukocytes and by leukocyte
trafficking. HSCs give rise to leukocyte subtypes (including
neutrophils), which feed back to the HSC niche, regulating both
HSC number and function. This crosstalk may function as a
biological rheostat during inflammation and in different disease
states, and this feedback system allows the BM to monitor
the periphery and to adjust leukocyte output according to
peripheral needs, although many of the finer details still remain
to be elucidated.
PLATELETS IN LEUKOCYTE
RECRUITMENT AND RESOLUTION OF
INFLAMMATION
Current research has expanded the appreciation of platelets
beyond their contribution to primary hemostasis, indicating that
they also actively participate in leukocyte recruitment, especially
neutrophils, and in the regulation of the host defense in response
to exogenous injuries (15). Platelets physically interact with
different leukocyte subsets during inflammatory processes (16),
which hold extensive implications for the leukocyte recruitment
into peripheral tissues and for the regulation of leukocyte cell
autonomous functions, including the formation and liberation
of neutrophil extracellular traps. In addition, platelets have also
been implicated in the resolution of inflammation (17). The
review by Rossaint et al. focuses on the role of platelets in
leukocyte recruitment during the initiation of the host defense,
and also discusses their participation in the resolution process
after acute inflammation.
MONOCYTE AND MACROPHAGE
TRAFFICKING
Teh et al. describe recent advances in the field of monocyte
trafficking. Monocytes are highly plastic cells which can perform
effector functions in their own right, or traffic into tissues
and differentiate into various monocyte-derived cell types, both
during homeostasis and in different diseases (18).Major advances
in understanding the role of monocytes and monocyte-derived
cells were possible in recent years due to development of imaging
techniques, but the authors point out that these cells are still
challenging to investigate due to their plasticity.
In an original research paper included in this Topic, Cui et al.
studied the role of the αLβ2 and αDβ2 integrins in macrophage
migration in tissues. They show that 3D amoeboid macrophage
migration is inhibited by high β2 integrin expression, whilst a
moderate expression of the integrin promotes it.
CATECHOLAMINES, GLUCOCORTICOIDS
AND SCAVENGER RECEPTORS
Ince et al. provide an exhaustive overview of the dynamics
of multiple leukocyte subsets with particular emphasis on
the molecular cues guiding their trafficking patterns during
baseline or inflammatory conditions. The first of these cues
are catecholamines, which are neurotransmitters produced by
the adrenal gland, sympathetic nerves and even leukocytes
themselves. Recent studies established important roles for
catecholamines in regulating the expression of adhesion
molecules and chemoattractants by endothelial cells, but also
through direct actions on leukocytes (19, 20). A second class of
cues is the glucocorticoids, a type of steroid hormones produced
by the adrenal gland. These hormones influence many aspects of
leukocyte behavior by generally reducing their adhesive capacity
(21, 22). This can induce, for example, potent demargination of
certain leukocyte types by attenuating interactions with vascular
cells (23). Because the presence of both signals display potent
circadian patterns, the review also discusses how these signals
contribute to diurnal rhythms in leukocyte trafficking.
The review by Patten and Shetty describes roles of scavenger
receptors expressed on endothelial cells (24), which regulate the
leukocyte trafficking. However, the roles of these receptors in
leukocyte migration are less well-understood than those of other
traditional adhesion receptors.
HEMATOLOGIC TUMOR CELL
TRAFFICKING
The trafficking of hematologic tumor cells is facilitated by
adhesion molecules and chemokines, a process that contributes
to progression of hematologic malignancies (4, 6). A common
feature of multiple myeloma, chronic lymphocytic leukemia and
acute lymphoblastic leukemia is the homing and lodging of
blood cancer cells in the BM, which favors their growth and
survival. The α4β1 integrin and the chemokine receptor CXCR4
are key molecules for cell trafficking into and out of the BM
in these hematologic neoplasias (25, 26). Redondo-Muñoz et al.
review the molecular players that regulate the trafficking of
neoplastic cells during development and progression of these
hematologic malignancies.
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